Pregled bibliografske jedinice broj: 1272164
Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study
Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study // Seminars in Arthritis and Rheumatism, 61 (2023), N/A, 7 doi:10.1016/j.semarthrit.2023.152209 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1272164 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Clinical features, treatment and outcome of
pediatric patients with severe cutaneous
manifestations in IgA vasculitis: Multicenter
international study
Autori
Sestan, Mario ; Kifer, Nastasia ; Sozeri, Betul ; Demir, Ferhat ; Ulu, Kadir ; Silva, Clovis A. ; Campos, Reinan T. ; Batu, Ezgi Deniz ; Koker, Oya ; Sapina, Matej ; Srsen, Sasa ; Held, Martina ; Gagro, Alenka ; Fonseca, Adriana Rodrigues ; Rodrigues, Marta ; Rigante, Donato ; Filocamo, Giovanni ; Baldo, Francesco ; Heshin-Bekenstein, Merav ; Giani, Teresa ; Kataja, Janne ; Frkovic, Marijan ; Ruperto, Nicolino ; Ozen, Seza ; Jelusic, Marija
Izvornik
Seminars in Arthritis and Rheumatism (0049-0172) 61
(2023);
N/A, 7
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
IgA vasculitis ; Henoch-Schonlein Purpura ; Severe cutaneous manifestations ; Nephritis ; Glucocorticoids
Sažetak
Objective: IgA vasculitis (IgAV) (formerly Henoch- Schönlein Purpura, HSP) rarely causes severe skin lesions in children. The purpose of the research was to determine whether severe skin manifestations were associated with a more severe disease course. Methods: Severe cutaneous manifestations were defined as presence of hemorrhagic vesicles, bullae, ulcerations and/or necroses. Data were collected retrospectively from 12 international tertiary university medical centers. Results: A total of 64 patients with the most severe skin changes in IgAV/HSP and median (Q1, Q3) age of 8.08 (5.08, 11.92) years at the disease onset were compared with 596 IgAV/HSP patients without these manfiestations and median (Q1, Q3) age of 6.33 (4.50, 8.92) years. The patients with severe cutaneous manifestations were older in comparison to other patients with IgAV/HSP (p<0.001), they developed nephritis more frequently (40.6% vs. 20.6%, p=0.001) with worse outcome of renal disease (p=0.001). This group of patients also had higher frequencies of severe gastrointestinal complications like hematochezia, massive bleeding and/or intussusception (29.3% vs. 14.8%, p<0.001). D-dimer concentrations were significantly higher in these patients (4.60 mg/L vs. 2.72 mg/L, p=0.003) and they had more frequent need for treatment with systemic glucocorticoids (84.4% vs. 37.2%, p<0.001) in comparison with the control group. Further multivariate analysis showed that severe cutaneous changes were associated with higher risk of developing nephritis [OR=3.1 (95%CI 1.04-9.21), p=0.042] and severe gastrointestinal complications [OR=3.65 (95%CI 1.08-12.37), p=0.038]. Conclusion: Patients with IgAV/HSP and severe skin manifestations had a more severe clinical course and more frequently required glucocorticoids compared to classic IgAV/HSP patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
IP-2019-04-8822 - Histološki, klinički, laboratorijski i genski prediktori ishoda bolesnika s Henoch-Schönleinovom purpurom i nefritisom (PURPURAPREDICTORS) (Jelušić, Marija, HRZZ - 2019-04) ( CroRIS)
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Osijek,
KBC Split,
Klinički bolnički centar Zagreb,
Medicinski fakultet, Split,
Medicinski fakultet, Osijek,
Sveučilište u Zagrebu,
Sveučilište J. J. Strossmayera u Osijeku,
Klinika za dječje bolesti,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Nastasia Kifer
(autor)
Marija Jelušić
(autor)
Matej Šapina
(autor)
Alenka Gagro
(autor)
Martina Held
(autor)
Marijan Frković
(autor)
Mario Šestan
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE